Archive for the ‘Clinical Trials / Drug Trials’ Category
The National Institutes of Health (NIH) announced an expanded ClinicalTrials.gov database. The database will accept basic results information, in addition to trial registrations.
The Effects Of Disclosing Financial Interests On Participation In Medical Research
Monday, October 6th, 2008
Knowing how an investigator is paid for running a research study surprisingly plays a small role in patients' willingness to take part in clinical trials. However, according to a new Johns Hopkins University study more participants are troubled when they are told that the investigator could profit or lose money depending on the results.
Clinical Trials In India 44% Less Expensive Than US Trials
Thursday, October 2nd, 2008
Conducting clinical trials in India is an average of 44% less expensive than conducting US-based trials, according survey data. A new study by pharmaceutical business intelligence leader Cutting Edge Information, "Streamlining Clinical Trials," finds that the average clinical trial costs pharmaceutical companies $125 million in the US compared to $70 million in India, on average.
More Minority Physicians Would Help Improve Minorities’ Participation In Clinical Trials, Opinion Piece Says
Wednesday, October 1st, 2008
"The first step in addressing the underrepresentation of black Americans in research ...
Determining What Works: Guidance For Health Research Design Gets An Overhaul
Tuesday, September 30th, 2008
New guidance from the Medical Research Council (MRC) on how best to conduct research into complex health and social interventions is published in the British Medical Journal and the MRC website.
Gaucher Disease - Protalix BioTherapeutics Provides Enrollment Update For The Phase III Clinical Trial Of PrGCD
Tuesday, September 23rd, 2008
Protalix BioTherapeutics, Inc. (Amex: PLX), today announced that the Company anticipates completion, during the second half of 2008, of enrollment in its on-going pivotal phase III clinical trial of prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD) for the treatment of Gaucher disease.
Clinical Trials: The Features And Promises Of The Brazilian Market
Sunday, September 21st, 2008
Frost & Sullivan will host a live briefing on Tuesday, September 23, at 3:00 pm EDT to provide industry participants an overview of a recently published study focusing on Clinical Trials Markets in Brazil. Over the years, Brazil has increasingly raised its attractiveness for pharmaceutical clinical trials and outsourcing due to cost advantages, considerable patient pool and quality resources.
Drug Information Association Conference To Present Latest Strategies In Clinical Trial Disclosure Compliance
Thursday, September 18th, 2008
Experts from government, the pharmaceutical and biotech industries, and medical device companies will discuss best practices to ensure compliance with clinical trial disclosure laws and regulations, the Clinical Trials.
PharmaPros Dataflow ManagerT Solution Benefits Study At Paradigm Spine
Thursday, September 18th, 2008
PharmaPros, a technical consulting and solutions provider specialising in data and workflow management for clinical trials, announced that it has entered into an agreement with Paradigm Spine, a worldwide provider of non-fusion and fusion spinal implant solutions with headquarters in New Yo
Novacea Update On Asentar(TM)
Sunday, September 14th, 2008
Novacea, Inc. (NASDAQ: NOVC), reported that it has received notice from the United States Food and Drug Administration (FDA) that the agency has released the clinical hold on the Asentar(TM) Investigational New Drug (IND) application.